Description
Vandetanib, marketed under the brand name CAPRELSA, It is an prescription medication that has been approved vandetanib (Caprelsa tablets; AstraZeneca Pharmaceuticals LP) for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable, locally advanced, or metastatic disease. On April 6, 2011
What is Caprelsa (vandetanib) ?
Caprelsa is a targeted therapy. It is an oral receptor tyrosine kinase inhibitor.
Caprelsa is used for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
How to order approved “Caprelsa (vandetanib) for Tablets” Medicine?
CAPRELSA (Vandetanib) Tablets is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing CAPRELSA and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.





